The excess financial burden of multidrug resistance in severe gram-negative infections in Singaporean hospitals

Annals of the Academy of Medicine Singapore

Volumn 41, Issue 5, 2012, Pages 189-193

  Ng, Esther ^a   Earnest, Arul ^b,c   Lye, David C ^a,b   Ling, Moi Lin ^d   Ding, Ying ^a   Hsu, Li Yang ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Antimicrobial resistance; Cohort study; Gram negative bacteraemia; Healthcare costs

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FINANCIAL MANAGEMENT; GRAM NEGATIVE SEPSIS; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; RETROSPECTIVE STUDY; SINGAPORE; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 84861885387     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Eggimann P, Pittet D. Infection control in the ICU. Chest 2001;120:2059-93.
2. Weber DJ, Raasch R, Rutala WA. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 1999;115(3 Suppl):34S-41S.
3. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis 2010;23:546-53.
4. Hsu LY, Tan TY, Tam VH, Kwa A, Fisher DA, Koh TH, et al. Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 2010;54:1173-8.
5. Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002;34:1600-6.
6. Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis. 2011;11:30-8.
7. Lye DC, Earnest A, Ling ML, Lee TE, Yong HC, Fisher DA, et al. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study. Clin Microbiol Infect. 2011 Jun 20 [Epub ahead of print].
8. Giske CG, Monnet DL, Cars O, Carmeli Y; ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 2008;52:813-21.
9. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother 2010;54:109-15.
10. Kallen AJ, Hidron AI, Patel J, Srinivasan A. Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010;31:528-31.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity disease classification system. Crit Care Med 1985;13:818-29.
13. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32.
14. Ministry of Health Singapore. Singapore's healthcare financing system. Available at: http://www.moh.gov.sg/mohcorp/uploadedFiles/Publications/Educational_Resources/2010/MOH_3M%20booklet%20(%20English%20)_2010.pdf Accessed 4 July 2011.
15. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791-7.
16. Cosgrove SE, Kaye KS, Eliopoulous GM, Carmeli Y. Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 2002;162:185-90.
17. Roberts RR, Scott RD 2nd, Hota B, Kampe LM, Abbasi F, Schabowski S, et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010;48:1026-35.
18. Hsu LY, Tan TY, Jureen R, Koh TH, Krishnan P, Tzer-PinLin R, et al. Antimicrobial drug resistance in Singapore hospitals. Emerg Infect Dis 2007;13:1944-7.
19. Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002;30:145-52.